{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:47Z","timestamp":1791389027889,"version":"4.3.3"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":593,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Roche Diagnostics K.K."}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Growth differentiation factor-15 (GDF15), a cytokine in the transforming growth factor family, is up-regulated in stress and inflammatory conditions and is elevated in patients with heart failure (HF). However, the age-specific attributes and prognostic significance of GDF15 across age remain unknown in chronic HF (CHF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Serum levels of GDF15 were examined in 942 hypertensive patients (median 68 years) with CHF from the SUPPORT trial across the four age groups [under 50 (n = 73), 51\u201359 (n = 158), 60\u201369 (n = 296), and 70\u201379 years (n = 415)] and in the continuous spectrum. Clinical correlates of GDF15 were explored using the classic stepwise and LASSO (least absolute shrinkage and selection operator) regression approaches. Interaction terms with age were tested in the LASSO regression approach. The associations with the composite outcome of HF hospitalization or all-cause death were investigated across ages. Median GDF15 levels (pg\/mL) increased along with aging, from 691 in under 50 years to 855 in 51\u201359 years, 1114 in 60\u201369 years, and 1516 in 70\u201379 years (trend P &amp;lt; 0.001). Age, sex, systolic blood pressure, history of diabetes, ischaemic heart disease, left ventricular (LV) end-systolic dimension, LV ejection fraction, estimated glomerular filtration rate, haemoglobin, N-terminal pro-brain natriuretic peptide (NT-proBNP), troponin, C-reactive protein, and the use of angiotensin-converting enzyme inhibitors, diuretics, and statins were mutually selected as clinical covariates of GDF15. The LASSO regression analysis identified significant interactions between age and the history of diabetes and NT-proBNP, with particularly robust associations in patients aged between 60 and 70 years. During the mean follow-up of 8.6 years, 474 composite endpoints of HF hospitalization or death occurred. GDF15 was associated with a higher risk of HF hospitalization or all-cause death [adjusted hazard ratio 1.84 (95% confidence interval 1.45\u20132.33)], with a particularly heightened risk in patients aged around 70 years (Pinteraction = 0.0008). The model with GDF15 on top of other established risk factors yielded marginally higher C-statistics compared with the model without GDF15 (0.803 and 0.796, P = 0.045). The additive value of GDF15 on top of other established risk factors appeared similar across ages. A universal cut-off value of 1400 pg\/mL performed well in discriminating between those with and without HF hospitalization or death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Some clinical correlates of GDF15 have an interaction with age. GDF15 is an important determinant of cardiovascular endpoints, particularly in patients aged around 70 years. The additive value of GDF15 appeared consistent across ages, suggesting the use of a universal cut-off value.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14738","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T06:00:25Z","timestamp":1709272825000},"page":"1666-1676","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic Significance of Growth Differentiation Factor-15 Across Age in Chronic Heart Failure"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4217-9497","authenticated-orcid":false,"given":"Kanako","family":"Teramoto","sequence":"first","affiliation":[{"name":"Department of Biostatistics, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8297-8624","authenticated-orcid":false,"given":"Kotaro","family":"Nochioka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine , 1-1 Seiryomachi, Aoba-ku, Sendai ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine , 1-1 Seiryomachi, Aoba-ku, Sendai ,","place":["Japan"]},{"name":"International University of Health and Welfare Graduate School , Narita ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine , 1-1 Seiryomachi, Aoba-ku, Sendai ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the SUPPORT Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"2026012113031624000_ehf214738-bib-0001","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth differentiation factor 15 as a biomarker in cardiovascular disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin Chem"},{"key":"2026012113031624000_ehf214738-bib-0002","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","volume":"64","author":"Siddiqui","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"2026012113031624000_ehf214738-bib-0003","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004566","article-title":"Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia","volume":"95","author":"Chai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2026012113031624000_ehf214738-bib-0004","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1164\/rccm.200712-1786OC","article-title":"Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism","volume":"177","author":"Lankeit","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012113031624000_ehf214738-bib-0005","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: A translational prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J Diabetes Res"},{"key":"2026012113031624000_ehf214738-bib-0006","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1681\/ASN.2016080919","article-title":"Growth differentiation factor-15 and risk of CKD progression","volume":"28","author":"Nair","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026012113031624000_ehf214738-bib-0007","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/01.RES.0000207919.83894.9d","article-title":"GDF15, a cardioprotective TGF-beta superfamily protein","volume":"98","author":"Ago","year":"2006","journal-title":"Circ Res"},{"key":"2026012113031624000_ehf214738-bib-0008","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/10408363.2019.1678565","article-title":"The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update","volume":"57","author":"Arkoumani","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2026012113031624000_ehf214738-bib-0009","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12799","article-title":"Plasma proteomic signature of age in healthy humans","volume":"17","author":"Tanaka","year":"2018","journal-title":"Aging Cell"},{"key":"2026012113031624000_ehf214738-bib-0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111228","article-title":"GDF15 as a biomarker of ageing","volume":"146","author":"Liu","year":"2021","journal-title":"Exp Gerontol"},{"key":"2026012113031624000_ehf214738-bib-0011","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1373\/clinchem.2006.076828","article-title":"Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay","volume":"53","author":"Kempf","year":"2007","journal-title":"Clin Chem"},{"key":"2026012113031624000_ehf214738-bib-0012","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1515\/cclm-2022-0135","article-title":"Reference ranges for GDF15, and risk factors associated with GDF15, in a large general population cohort","volume":"60","author":"Welsh","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2026012113031624000_ehf214738-bib-0013","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jjcc.2013.02.011","article-title":"Supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial\u2014Rationale and design","volume":"62","author":"Sakata","year":"2013","journal-title":"J Cardiol"},{"key":"2026012113031624000_ehf214738-bib-0014","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/eurheartj\/ehu504","article-title":"Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: The supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial","volume":"36","author":"Sakata","year":"2015","journal-title":"Eur Heart J"},{"key":"2026012113031624000_ehf214738-bib-0015","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.106.650846","article-title":"Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome","volume":"115","author":"Wollert","year":"2007","journal-title":"Circulation"},{"key":"2026012113031624000_ehf214738-bib-0016","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/ATVBAHA.110.213512","article-title":"Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: Observations from PROVE IT-TIMI 22","volume":"31","author":"Bonaca","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026012113031624000_ehf214738-bib-0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101569","article-title":"GDF15, an emerging key player in human aging","volume":"75","author":"Conte","year":"2022","journal-title":"Ageing Res Rev"},{"key":"2026012113031624000_ehf214738-bib-0018","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.109.928846","article-title":"Serial measurement of growth-differentiation factor-15 in heart failure: Relation to disease severity and prognosis in the Valsartan Heart Failure Trial","volume":"122","author":"Anand","year":"2010","journal-title":"Circulation"},{"key":"2026012113031624000_ehf214738-bib-0019","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ejhf.431","article-title":"Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction","volume":"18","author":"Chan","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012113031624000_ehf214738-bib-0020","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jchf.2017.07.013","article-title":"Utility of growth differentiation factor-15, a marker of oxidative stress and inflammation, in chronic heart failure: Insights from the HF-ACTION study","volume":"5","author":"Sharma","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026012113031624000_ehf214738-bib-0021","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3109\/1354750X.2011.580006","article-title":"Growth differentiation factor 15 in cardiovascular diseases: From bench to bedside","volume":"16","author":"Xu","year":"2011","journal-title":"Biomarkers"},{"key":"2026012113031624000_ehf214738-bib-0022","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/eurjhf\/hfs120","article-title":"Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support","volume":"14","author":"Lok","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026012113031624000_ehf214738-bib-0023","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1373\/clinchem.2012.190322","article-title":"Clinical and genetic correlates of growth differentiation factor 15 in the community","volume":"58","author":"Ho","year":"2012","journal-title":"Clin Chem"},{"key":"2026012113031624000_ehf214738-bib-0024","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1093\/eurheartj\/ehu216","article-title":"Heart failure in younger patients: The Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)","volume":"35","author":"Wong","year":"2014","journal-title":"Eur Heart J"},{"key":"2026012113031624000_ehf214738-bib-0025","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/eurjhf\/hfs130","article-title":"Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction","volume":"14","author":"Santhanakrishnan","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026012113031624000_ehf214738-bib-0026","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/1354750X.2010.510580","article-title":"Growth differentiation factor 15 in different stages of heart failure: Potential screening implications","volume":"15","author":"Wang","year":"2010","journal-title":"Biomarkers"},{"key":"2026012113031624000_ehf214738-bib-0027","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","article-title":"GDF15: Emerging biology and therapeutic applications for obesity and cardiometabolic disease","volume":"17","author":"Wang","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"2026012113031624000_ehf214738-bib-0028","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ahj.2013.09.013","article-title":"Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study)","volume":"167","author":"Schopfer","year":"2014","journal-title":"Am Heart J"},{"key":"2026012113031624000_ehf214738-bib-0029","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/eurheartj\/ehac577","article-title":"Growth differentiation factor 15 and cardiovascular risk: Individual patient meta-analysis","volume":"44","author":"Kato","year":"2023","journal-title":"Eur Heart J"},{"key":"2026012113031624000_ehf214738-bib-0030","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jchf.2013.10.005","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure","volume":"2","author":"Gaggin","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026012113031624000_ehf214738-bib-0031","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.009526","article-title":"Multimarker analysis of serially measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, creatinine, and prognosis in acute heart failure","volume":"16","author":"G\u00fcrg\u00f6ze","year":"2023","journal-title":"Circ Heart Fail"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/3\/1666\/64070542\/eschf_11_3_1666.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/3\/1666\/64070542\/eschf_11_3_1666.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:03:26Z","timestamp":1769018606000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/3\/1666\/8234058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,1]]},"published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14738","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"2023-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}